Childhood cancers trials in China

In China 609 Also abroad 2483

609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma
Where
Chengdu
Age
16 years to 70 years
People
34
Run by
Sichuan University
See details and how to joinNCT07014943
No phaseTaking people
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
Where
Guangzhou
Age
12 years to 75 years
People
20
Run by
Affiliated Hospital of Guangdong Medical University
See details and how to joinNCT06940960
Phase 2Taking people
Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations
Where
Suzhou
Age
14 years and over
People
32
Run by
yuejun Liu
See details and how to joinNCT07012447
Phase 1/2Taking people
Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
Where
Shanghai
Age
2 years to 75 years
People
50
Run by
Shanghai Tongji Hospital, Tongji University School of Medicine
See details and how to joinNCT06987916
Phase 2Taking people
Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT
Where
Beijing
Age
12 years to 65 years
People
35
Run by
Peking University People's Hospital
See details and how to joinNCT06130579
No phaseTaking people
Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery
Where
Hangzhou
Age
14 years to 70 years
People
30
Run by
Zhejiang University
See details and how to joinNCT06164769
No phaseTaking people
Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
Where
Chongqing
People
800
Run by
Mingzhao Xiao
See details and how to joinNCT06088134
No phaseTaking people
Deep Learning Radiomics Model for Predicting Post-cystectomy Outcome in Muscle Invasive Bladder Cancer
Where
Chongqing
People
500
Run by
First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT06092450
Phase 2Enrolling by invitation
Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis
Where
Zhengzhou
Age
Up to 75 years
People
216
Run by
Yingjuan Zheng
See details and how to joinNCT06999148
Phase 1/2Enrolling by invitation
Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia
Where
Tianjin
Age
14 years to 55 years
People
80
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT03031249
Phase 1/2Taking people
Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML
Where
Tianjin
Age
15 years and over
People
29
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06757855
No phaseTaking people
Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma
Where
Hefei
Age
3 years and over
People
18
Run by
Anhui Provincial Hospital
See details and how to joinNCT06961669
No phaseTaking people
A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)
Where
Beijing
Age
18 months and over
People
300
Run by
Peking University First Hospital
See details and how to joinNCT06991868
No phaseTaking people
Intraoperative Neuromuscular Monitoring and Its Impact on Pre- and Postoperative Acoustic Outcomes in Thyroid Surgery
Where
Fuzhou
People
100
Run by
Fujian Medical University
See details and how to joinNCT06254859
Phase 2/3Taking people
Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
Where
Shanghai
Age
14 years to 75 years
People
126
Run by
Ruijin Hospital
See details and how to joinNCT06972641
No phaseTaking people
Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes
Where
Fuzhou
People
300
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT06977906
No phaseNot yet taking people in China
Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors
Where
Guangzhou
People
40
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT06979115
Early phase 1Taking people
UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.
Where
Hefei
Age
3 years to 70 years
People
10
Run by
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT06092047
No phaseEnrolling by invitation
Risk Model for Metastasis Detection of Neuroblastoma
Where
Hangzhou, Shanghai, Shenzhen
People
500
Run by
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06703944
Phase 2Taking people
Safety and Efficacy of Pucotenlimab in pLECC
Where
Guangzhou
Age
1 year to 18 years
People
33
Run by
Sun Yat-sen University
See details and how to joinNCT06969534
Early phase 1Taking people
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
Where
Shanghai
Age
1 year to 12 years
People
10
Run by
Eye & ENT Hospital of Fudan University
See details and how to joinNCT06972602
Phase 2Taking people
BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma
Where
Shanghai
Age
8 years to 65 years
People
30
Run by
Ruijin Hospital
See details and how to joinNCT04072042
Phase 1/2Taking people
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
Where
Beijing, Shanghai, Zhanjiang
Age
14 years to 70 years
People
36
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06925464
No phaseEnrolling by invitation
Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer
Where
Shanghai
People
500
Run by
Shanghai Chest Hospital
See details and how to joinNCT06962449
Phase 2Taking people
Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention
Where
Shanghai
Age
14 years to 55 years
People
59
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06686108